RAC 0.80% $1.86 race oncology ltd

Industry news, page-1492

  1. 145 Posts.
    lightbulb Created with Sketch. 642
    Interestingly, today Reach Pharmaceuticals has announced that the TGA has granted dexrazoxane Orphan Designation in Australia.

    https://hotcopper.com.au/data/attachments/5715/5715422-253d92c6ddba13ef6eecacff56abeacd.jpg
    Reach have 6 months now I believe to submit their registration dossier to the TGA for evaluation.

    Whilst it doesn't have a direct impact on RAC I do find it interesting that the noise around cardio-oncology and cardioprotection is starting to be amplified globally. RAC couldn't be better positioned to become a global leader in this space. Looking forward to seeing how the team plan to execute on cardio-oncology in the new strategy.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.86
Change
-0.015(0.80%)
Mkt cap ! $316.8M
Open High Low Value Volume
$1.88 $1.88 $1.79 $163.0K 89.00K

Buyers (Bids)

No. Vol. Price($)
2 34299 $1.84
 

Sellers (Offers)

Price($) Vol. No.
$1.86 3635 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.